Mulia Industrindo Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Mulia Industrindo Tbk trades at Rp240 (market cap 1.59T, 23.4K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Mulia Industrindo Tbk is far larger — about 9.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 23.4K). Which is the better fit depends on your goals.
| MLIA | OBAT | |
|---|---|---|
Market Cap | 1.59T | 167.37B |
Volume | 23.4K | 96.7K |
Lot | 234 | 967 |
Turnover | 5.6M | 23.82M |
Average Price | 239.28 | 246.34 |
Value | 5.6M | 23.82M |
Indicative Equilibrium Price | 240 | 248 |
Indicative Equilibrium Volume | 11 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Mulia Industrindo Tbk (the company) was established based on Deed No. 15 dated November 5, 1986 of Liliani Handajawati Tamzil S.H., notary in Jakarta, as amended by deed No. 7 dated May 6, 1987 of the same notary.. The company's articles of association have been amended several times, most recently on January 21, 1997 regarding the change of the Company's name and par value per share. The company is one of the companies of the Mulia Group. The company started its commercial operations in 1990.
Read more on MLIA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →